Are there any alternative, hypofractionated RT courses for patients with DLBCL that can be used during the COVID-19 pandemic?

ILROG recently came out with guidelines pasted below:

Synopsis of ILROG Recommendations for Administering Radiotherapy for Hematological Malignancies During Emergency Conditions of the COVID-19 Pandemic

• We are facing an increased demand for RT to substitute or complement systemic therapy deemed immunosuppressive or too toxic in the current high-risk environment for patients with hematological malignancies, particularly if old and frail

• Resources for delivering RT may be under stress due to ...

I do not think any patient should have their care compromised because other patients have COVID.

Do you want your cardiac care compromised because someone else has COVID?

Will the ILROG be my expert witness if I am sued for malpractice due to brachial plexopathy because I used hypofractionation?

We should resume standard radiation oncology and stop using fractionation schemes that have, at most, one year follow-up to assess complications and normal tissue tolerance, let alone what our in-field f...